Answers are grounded in this paper and cite their sources.
Scoping review maps medicine donation programs, revealing operational impacts and access equity in healthcare.
Coordinated medicine donations improve treatment access, especially in low- and middle-income countries and humanitarian contexts. However, heterogeneous practices raise concerns regarding efficiency, sustainability, and alignment with health priorities. This scoping review mapped evidence on medicine donation programs, focusing on operational mechanisms, public health impacts, and contribution to reducing access inequities. This study followed Joanna Briggs Institute methodology and was reported according to PRISMA-ScR guidelines. Systematic searches were performed in PubMed, Scopus, and Google Scholar (July 11, 2025). Eligible sources included original studies, expert opinions, and grey literature addressing donation programs or solidarity pharmacies. Data were extracted on study characteristics, donated medicines, contexts, involved actors, and responses to guiding questions. Forty-one publications were included, most of them published between 1999 and 2020 (n=30; 75%), with over half being observational studies (n=22; 55%). Research mainly focused on Africa (n=9; 22.5%) and Europe (n=7; 17.5%), with pharmacists often playing a central role in donation management (n=12; 29,2%). Three main themes emerged: heterogeneous implementation models, ranging from global partnerships to local reuse initiatives in high-income countries; public health impacts, including disease control and expanded access, as well as logistical, regulatory, and quality challenges; and contributions to reducing inequities, particularly in emergencies, neglected diseases, and high-cost medicines. Medicine donation programs are strategic tools but should complement, not replace, sustainable financing and pharmaceutical policies. Their effectiveness depends on governance, alignment with health priorities, and monitoring. Future research should assess long-term outcomes and cost-effectiveness to guide ethical and sustainable global health strategies. • 41 studies mapped medicine donation programs worldwide (1988–2025). • Models varied from global partnerships to local reuse and solidarity pharmacies. • Public health effects ranged from disease control to logistical and quality barriers. • Donations improved equity in emergencies, neglected diseases, and costly medicines. • Success relied on governance, monitoring, and alignment with national priorities.
No takes yet. Share an insight, caveat, or question.
Vieira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: